• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

byPuja UmaretiyaandCordelia Ross
June 8, 2015
in Infectious Disease, Nephrology, Pediatrics, Urology
Reading Time: 3 mins read
Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk
Share on FacebookShare on TwitterShare on LinkedIn

1. This prospective cohort study identified several risk factors for recurrent febrile and symptomatic urinary tract infection (UTI) in children, including vesicoureteral reflux (VUR), bowel and bladder dysfunction (BBD), and baseline renal scarring. Children with both VUR and BBD were at highest risk of recurrent febrile or symptomatic UTI.

2. There was no difference in renal scarring rates among children with and without VUR at the end of the 2-year study period.

Evidence Rating Level: 2 (Good)

Study Rundown: UTIs are a common cause of serious bacterial infection in the pediatric population and can result in long-term sequelae, such as recurrent UTIs and renal scarring. This prospective study of children with a history or 1 or 2 febrile/symptomatic UTIs sought to determine risk factors for recurrent UTI and renal scarring, and to compare rates of these complications among children with and without VUR. During the 2-year study period, children with VUR had higher rates of recurrent febrile/symptomatic UTI compared to children without VUR. BBD and presence of renal scarring at baseline were also associated with recurrent UTI. There was no significant difference in renal scarring between children with and without VUR. This study is limited by a small sample size and differences among sites with regard to management of BBD. Nonetheless, this study highlights important risk factors for recurrent UTIs in children to help physicians determine which children may benefit from antimicrobial prophylaxis.

Click to read the study, published today in Pediatrics

Relevant Reading: Antibiotic prophylaxis and recurrent urinary tract infection in children.

RELATED REPORTS

Iterum’s Sulopenem receives FDA approval for treatment of uncomplicated urinary tract infections

#VisualAbstract: Computerized provider order entry prompts can reduce empiric extended-spectrum antibiotic use in patients hospitalized with urinary tract infection

In-Depth [prospective cohort study]:  A total of 305 children aged 2 to 71 months with VUR and 195 children without VUR from multiple institutions were observed over a 2-year period. All children had a history of 1 or 2 febrile or symptomatic UTIs prior to enrollment. Parents were contacted every 2 months to ascertain any urinary symptoms or illnesses, and patients were seen in follow-up at 6, 12, 18, and 24 months with DMSA scan to assess for renal scarring and BBD assessment at 1 and 2 years. Children with VUR had a significantly increased rate of recurrent febrile or symptomatic UTI compared to children without VUR (Kaplan-Meier* estimate 25.4% vs. 17.3%). This risk was increased in children with grade III or grade IV VUR, who had a Kaplan-Meier risk estimate of 28.9%. Baseline renal scarring was associated with an increased risk of recurrent febrile or symptomatic UTI (hazard ratio [HR]: 3.21; 95% CI: 1.40-7.33), as was age of 36 to 71 months (HR: 2.49; 95% CI: 1.61-3.85), second UTI at enrollment (HR: 2.08; 95% CI: 1.24-3.50), BBD (HR: 2.01; 95% CI: 1.07-3.76), and white race (HR: 1.70; 95% CI: 1.01-2.86). Children with VUR and BBD had the highest risk of recurrent UTI (Kaplan-Meier estimate 56%) There was no significant difference in renal scarring rates between children with and without VUR.

*The Kaplan-Meier risk estimate is a measure of survival, with higher percentages indicating greater risk of morbidity and mortality due to a certain disease pathology. In this study, it was used to estimate the proportion of children experiencing recurrent febrile or symptomatic UTI in a 2-year period.

Image: CC

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: urinary tract infection in childrenUTI
Previous Post

Youth weapon violence linked to psychological consequences

Next Post

Assessment of chest pain with CT angiography as effective as radionuclide imaging

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Pharma

Iterum’s Sulopenem receives FDA approval for treatment of uncomplicated urinary tract infections

November 11, 2024
#VisualAbstract: Computerized provider order entry prompts can reduce empiric extended-spectrum antibiotic use in patients hospitalized with urinary tract infection
StudyGraphics

#VisualAbstract: Computerized provider order entry prompts can reduce empiric extended-spectrum antibiotic use in patients hospitalized with urinary tract infection

April 23, 2024
Parental nonmedical prescription opioid use linked to adolescent use
Chronic Disease

Gepotidacin safe and effective for treatment of uncomplicated urinary tract infections

April 5, 2024
#VisualAbstract: Cefepime-Taniborbactam is superior to meropenem for the treatment of complicated urinary tract infection
StudyGraphics

#VisualAbstract: Cefepime-Taniborbactam is superior to meropenem for the treatment of complicated urinary tract infection

February 16, 2024
Next Post
Assessment of chest pain with CT angiography as effective as radionuclide imaging

Assessment of chest pain with CT angiography as effective as radionuclide imaging

Endostatin directly binds androgen receptors to treat prostate cancer [PreClinical]

Statin medications linked to memory impairment

2 Minute Medicine Rewind June 1 – June 7, 2015

2 Minute Medicine Rewind June 1 – June 7, 2015

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.